Retinal Precursors and the Development of Geographic Atrophy in Age-Related Macular Degeneration

Ophthalmology

Volumn 115, Issue 6, 2008, Pages 1026-1031

  Klein, Michael L ^a,b   Ferris III, Frederick L ^c   Armstrong, Jane ^d   Hwang, Thomas S ^a,b   Chew, Emily Y ^c   Bressler, Susan B ^e   Chandra, Suresh R ^d  

^a DEVERS EYE INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUSEN; EYE REFRACTION; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA INJURY; RETINA LESION; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; STEREOSCOPIC VISION; UNITED STATES;

AGED; ATROPHY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; PHOTOGRAPHY; PIGMENT EPITHELIUM OF EYE; RETINAL DRUSEN; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 44349085868     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.08.030     Document Type: Article

References (22)

1. Smith W., Assink J., Klein R., et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 108 (2001) 697-704
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol 117 (1999) 1329-1345
3. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
4. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
5. Avery R.L., Pieramici D.J., Rabena M.D., et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113 (2006) 363-372
6. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
7. Klein R., Davis M.D., Magli Y.L., et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98 (1991) 1128-1134
8. Sarks J.P., Sarks S.H., and Killingsworth M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 2 (1988) 552-557
9. Sunness J.S., Gonzalez-Baron J., Applegate C.A., et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 106 (1999) 1768-1779
10. Maguire P., and Vine A.K. Geographic atrophy of the retinal pigment epithelium. Am J Ophthalmol 102 (1986) 621-625
11. Schatz H., and McDonald H.R. Atrophic macular degeneration: rate of spread of geographic atrophy and visual loss. Ophthalmology 96 (1989) 1541-1551
12. Gass J.D. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90 (1973) 206-217
13. Sarks S.H. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol 10 (1982) 91-97
14. Sarks J., Tang K., Killingsworth M., et al. Development of atrophy of the retinal pigment epithelium around disciform scars. Br J Ophthalmol 90 (2006) 442-446
15. Sunness J.S. Choroidal neovascularisation and atrophy. Br J Ophthalmol 90 (2006) 398-399
16. Sunness J.S., Gonzalez-Baron J., Bressler N.M., et al. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 106 (1999) 910-919
17. Holz F.G., Bellman C., Staudt S., et al. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42 (2001) 1051-1056
18. Hwang J.C., Chan J.W., Chang S., and Smith R.T. Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 47 (2006) 2655-2661
19. Schmitz-Valckenberg S., Bindewald-Wittich A., Dolar-Szczasny J., et al. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci 47 (2006) 2648-2654
20. Hopkins J., Walsh A., and Chakravarthy U. Fundus autofluorescence in age-related macular degeneration: an epiphenomenon?. Invest Ophthalmol Vis Sci 47 (2006) 2269-2271
21. Bindewald A., Bird A.C., Dandekar S.S., et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci 46 (2005) 3309-3314
22. Holz F.G., Bindewald-Wittich A., Fleckenstein M., et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 143 (2007) 463-472